Globaldata's analysis focuses on three key indicators, which include HTA outcomes in the 5EU and the entry of newly priced ...

Bavarian Nordic is successfully navigating a sentiment-changing vaccine landscape, posting Q1 revenues significantly up from ...

HLS Therapeutics has signed an agreement with Esperion Therapeutics for commercialising Nexletol and Nexlizet in Canada.

Novo Nordisk has cut its sales and profits forecasts for 2025 due to lower demand in the US for blockbuster weight loss and ...

Viralgen has partnered biotech company Trogenix, aiming to accelerate the development of gene therapy for glioblastoma.

BioVaxys Technology and Sona Nanotech have signed an agreement to develop cancer therapeutics, utilising the DPX platform ...

The US Food and Drug Administration (FDA) has set an "aggressive" timeline to implement genAI across the agency by 30 June ...

ARS Pharmaceuticals has announced the availability of neffy (epinephrine nasal spray) 1mg in the United States.

The Vivo Opportunity Fund has already catalysed a plethora of medicine development via biotech investments in its first two ...

The deal builds on an existing research collaboration between Eli Lilly and Alchemab to discover new ALS drugs.